Abstract
Esophageal cancer is a highly malignant disease with a cure rate of less than 20%. Less than 40% of patients present with localized and resectable disease. Both surgery and combined chemoradiation therapy are important therapeutic modalities in curative treatment for esophageal cancer. Radiation therapy plays an important role in palliation of symptoms caused by advanced local or metastatic disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Al-Sarraf M, Martz K, Herskovic A et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284
Ando N, Iizuka T, Ide H et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study — JCOG9204. J Clin Oncol 21:4592–4596
Armanios M, Xu R, Forastiere AA et al. (2004) Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group. J Clin Oncol 22:4495–4499
Arnott SJ, Duncan W, Kerr GR et al. (1992) Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24:108–113
Arnott SJ, Duncan W, Gignoux M et al. (2005) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev (4):CD001799
Bedenne L, Michel P, Bouché O et al. (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168
Bosset J, Gignoux M, Triboulet J et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161–167
Byhardt RW, Martin L, Pajak TF et al. (1993) The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer — analysis of a Radiation Therapy Oncology Group protocol. Int J Radiat Oncol Biol Phys 27:537–544
Coia LR, Soffen EM, Schultheiss TE et al. (1993) Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer 71:281–286
Cooper JS, Guo MD, Herskovic A et al. (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623–1627
Crehange G, Maingon P, Peignaux K et al. (2007) Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol 25:4895–4901
Emami B, Lyman J, Brown A et al. (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122
Flamen P, Lerut A, Van Cutsem E et al. (2000) Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18:3202–3210
Fok M, Sham JS, Choy D et al. (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147
Gaspar LE, Nag S, Herskovic A et al. (1997) American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys 38:127–132
Gaspar LE, Winter K, Kocha WI et al. (2000) A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer 88:988–995
Gebski V, Burmeister B, Smithers BM et al. (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234
Gignoux M, Roussel A, Paillot B et al. (1987) The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11:426–432
Greene FL, Page DL, Fleming ID et al. (2002) American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual, 6th edn. Springer-Verlag, Berlin Heidelberg New York
Hayter CR, Huff-Winters C, Paszat L et al. (2000) A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. Radiother Oncol 56:329–333
Herskovic A, Martz K, al-Sarraf M et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598
Homs MY, Steyerberg EW, Eijkenboom WM et al. (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364:1497–1504
Hong TS, Crowley EM, Killoran J et al. (2006) Considerations in treatment planning for esophageal cancer. Semin Radiat Oncol 17:53–61
Hulscher JB, van Sandick JW, de Boer AG et al. (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669
Hussey D, Barakley T, Bloedorn F (1980) Carcinoma of the esophagus, 3rd edn. Lea & Febiger, Philadelphia
Jacob J, Seitz JF, Langlois C et al. (1999) Definitive concurrent chemo-radiation therapy in squamous cell carcinoma of the esophagus: preliminary results of a French randomized trial comparing standard versus split-course irradiation (FN-CLCC-FFCD9305). Proc Am Soc Clin Oncol 18:1035a
Japanese Esophageal Oncology Group (1993) A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 104:203–207
Kato H, Miyazaki T, Nakajima M et al. (2005) The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 103:148–156
Katsoulis IE, Wong WL, Mattheou AK et al. (2007) Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study. Int J Surg 5:399–403
Kelly S, Harris KM, Berry E et al. (2001) A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49:534–539
Kelsen DP, Ginsberg R, Pajak TF et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984
Kelsen DP, Winter KA, Gunderson LL et al. (2007) Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25:3719–3725
Konski AA, Cheng JD, Goldberg M et al. (2007) Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys 69:358–363
Launois B, Delarue D, Campion JP et al. (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153:690–692
Macdonald JS, Smalley SR, Benedetti J et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730
Minsky BD, Pajak TF, Ginsberg RJ et al. (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174
Moureau-Zabotto L, Touboul E, Lerouge D et al. (2005) Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63:340–345
MRC (Medical Research Council) Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in esophageal cancer: a randomized controlled trial. Lancet 359:1727–1733
National Comprehensive Cancer Network (2008) Clinical practice guidelines in oncology: esophageal Cancer. Version 1.2008. Available at http://www.nccn.org/professionals/physician_gls/PDF/esophageal.pdf. Accessed on May 22, 2008
Ott K, Weber WA, Lordick F et al. (2006) Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24:4692–4698
Pearson JG (1977) The present status and future potential of radiotherapy in the management of esophageal cancer. Cancer 39[2 Suppl]: 882–890
Picus D, Balfe DM, Koehler RE et al. (1983) Computed tomography in the staging of esophageal carcinoma. Radiology 146:433–438
Rankin SC, Taylor H, Cook GJ et al. (1998) Computed tomography and positron emission tomography in the preoperative staging of oesophageal carcinoma. Clin Radiol 53:659–665
Salonen O, Kivisaari L, Standertskjöld-Nordenstam CG et al. (1987) Computed tomography in staging of oesophageal carcinoma. Scand J Gastroenterol 22:65–68
Siewert JR, Stein HJ, Feith M et al. (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234:360–367; discussion 368–369
Stahl M, Stuschke M, Lehmann N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317
Ténière P, Hay JM, Fingerhut A et al. (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173:123–130
Tepper J, Krasna M, Niedzwiecki D et al. (2006) Superiority of tri-modality therapy to surgery alone in esophageal caner: results of CALGB 9781. J Clin Oncol 24[suppl 18S]:4012
Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543
van Meerten E, van der Gaast A (2005) Systemic treatment for oesophageal cancer. Eur J Cancer 41:664–672
Walsh TN, Noonan N, Hollywood D et al (1996) A comparison of multimodel therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467
Wang M, Gu XZ, Yin WB et al. (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16:325–327
Wieder HA, Brucher BL, Zimmermann F et al. (2004) Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22:900–908
Wu VW, Sham JS, Kwong DL (2004) Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer. Br J Radiol 77:568–572
Xiao ZF, Yang ZY, Miao YJ et al. (2005) Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys 62:82–90
Zieren HU, Müller JM, Jacobi CA et al. (1995) Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 19:444–449
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lu, J.J. (2008). Esophageal Cancer. In: Lu, J.J., Brady, L.W. (eds) Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77385-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-540-77385-6_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77384-9
Online ISBN: 978-3-540-77385-6
eBook Packages: MedicineMedicine (R0)